Aslani, Jack Perez .

HRN: 22-76-89  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2025
CEFUROXIME 750MG (VIAL)
06/06/2025
06/13/2025
IV
350 MG
Q8H
PCAP C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: